English
Swedish
Finnish
Front page
Investors
Financial Reports
LinkedIn
Tweet
Facebook
2019
Q4
Oriola Q4 2019 Financial Statements Release.pdf
Oriola_Q4 2019_Presentation.pdf
Q3
Oriola Q3 2019 presentation.pdf
Oriola Interim Report Q3 2019.pdf
Q2
Oriola_Q2 2019.pdf
Oriola Interim Report Q2 2019.pdf
Q1
Oriola Q1 2019 presentation.pdf
Oriola Q1 2019 Interim Report.pdf
2018
Q4
Oriola_Q4_2018 presentation.pdf
Oriola 2018 Financial Statements Release.pdf
Q3
Oriola Q3 2018 presentation.pdf
Oriola Q3 2018 Interim report.pdf
Q2
Oriola_Q2_2018_Presentation.pdf
Oriola Q2 2018 Half Year Financial Report.pdf
Q1
Oriola_Q1_2018_Presentation.pdf
Oriola Q1 2018 Interim report.pdf
2017
Q4
Oriola Q4 2017 Financial Statement Release.pdf
Q3
Presentation Oriola Q3 2017 Interim Report.pdf
Oriola Q3 2017 Interim Report.pdf
Q2
Presentation Oriola Q2 2017 Half Year Financial Report.pdf
Oriola Q2 2017 Half Year Financial Report.pdf
Q1
Presentation Oriola Q1 2017 Interim Report.pdf
Oriola Q1 2017 Interim Report.pdf
2016
Q4
Presentation Oriola-KD Financial Statements Release 2016.pdf
Oriola-KD 2016 Financial Statements Release.pdf
Q3
Presentation interim report 1.1.-30.9.2016.pdf
Oriola-KD Corporation interim report 1 Jan 30 Sep 2016.pdf
Q2
Presentation interim report 1.1.-30.6.2016.pdf
Oriola-KD Corporation interim report 1 Jan - 30 June 2016.pdf
Q1
Oriola-KD Corporation interim report 1 Jan - 31 March 2016.pdf
Presentation interim report 1.1. - 31.3.2016.pdf
2015
Q4
Presentation Oriola-KD Financial Statements Release 2015.pdf
Oriola-KD 2015 Financial Statements Release.pdf
Q3
Oriola-KD Corporation interim report 1 Jan - 30 Sep 2015.pdf
Presentation interim report 1 January 30 September 2015.pdf
Q2
Oriola-KD Corporation Interim Report for 1 January – 30 June 2015.pdf
Presentation interim report 1 January - 30 June 2015.pdf
Q1
Oriola-KD Corporation interim report 1 Jan - 31 Mar 2015.pdf
Presentation interim report 1 January 31 March 2015.pdf
2014
Q4
Oriola-KD Financial Statements Release 2014.pdf
Presentation OriolaKD Financial Statements Release 2014.pdf
Q3
Oriola-KD Interim Report 1 Jan 30 Sep 2014 English.pdf
Presentation Interim Report 1 January - 30 September 2014.pdf
Q2
Oriola-KD Corporation interim report 1 Jan - 30 Jun 2014.pdf
Presentation Interim Report 1 January 30 June 2014.pdf
Q1
Oriola-KD Corporation interim report 1 Jan - 31 Mar 2014.pdf
Presentation interim report 1 January 31 March 2014.pdf
2013
Q4
Oriola-KD Corporations Financial Statements Release 2013.pdf
Presentation Oriola-KD Corporations Financial Statements Release 2013.pdf
Q3
Interim Report for 1 January-30 September 2013.pdf
Presentation Interim Report for 1 January-30 September 2013.pdf
Q2
Interim Report 1 January - 30 June 2013.pdf
Presentation interim report 1 January - 30 June 2013.pdf
Q1
Interim Report 1 January - 31 March 2013.pdf
Presentation interim report 1 January - 31 March 2013.pdf
2012
Q4
Oriola-KD Corporations Financial Statements Release for 2012.pdf
Presentation Oriola-KD Financial statements release 2012.pdf
Q3
Oriola-KD Q3 2012_English.pdf
Presentation interim report 1 January-30 September 2012.pdf
Q2
Interim Report 1 January - 30 June 2012.pdf
Presentation interim report 1 January - 30 June 2012.pdf
Q1
Interim Report 1 January - 31 March 2012.pdf
Presentation interim report 1 January - 31 March 2012.pdf
2011
Q4
Financial statements 1 January - 31 December 2011.pdf
Presentation for financial statements 1 January - 31 December 2011.pdf
Q3
Interim report for 1 January- 30 September 2011.pdf
Presentation for interim report 1 January-30 September 2011.pdf
Q2
Interim report 1 January - 30 June 2011.pdf
Presentation for interim report 1 January - 30 June 2011.pdf
Q1
Interim report 1 January - 31 March 2011.pdf
Presentation for interim report 1 January - 31 March.pdf
2010
Q4
Financial statements 1 January - 31 December 2010.pdf
Presentation for financial statements 1 January - 31 december 2010.pdf
Q3
Interim report 1 January - 30 September 2010.pdf
Presentation for interim report 1 January - 30 September.pdf
Q2
Interim report 1 January - 30 June 2010.pdf
Presentation for interim report 1 January - 30 June 2010.pdf
Q1
Interim report 1 January - 31 March 2010.pdf
Presentation for interim report 1 January - 31 March 2010.pdf
2009
Q4
Financial statements 1 January - 31 December 2009.pdf
Presentation for financial statements 1 January - 31 December 2009.pdf
Q3
Interim report 1 January - 30 September 2009.pdf
Presentation for interim report 1 January - 30 September 2009.pdf
Q2
Interim report 1 January - 30 June 2009.pdf
Presentation for interim report 1 January - 30 June 2009.pdf
Q1
Interim report 1 January - 31 March 2009.pdf
Presentation for interim report 1 January - 31 March 2009.pdf
2008
Q4
Financial statements 1 January - 31 December 2008.pdf
Presentation for financial statements 1 January - 31 December 2008.pdf
Q3
Interim report 1 January - 30 September 2008.pdf
Presentation for interim report 1 January - 30 September 2008.pdf
Q2
Interim report 1 January - 30 June 2008.pdf
Presentation for interim report 1 January - 30 June 2008.pdf
Q1
Interim report 1 January - 31 March 2008.pdf
Presentation for interim report 1 January - 31 March 2008.pdf
2007
Q4
Financial statements 1 January - 31 December.pdf
Presentation for financial statements 1 January 31 December.pdf
Q3
Interim report 1 January - 30 September 2007.pdf
Presentation for interim report 1 January - 30 September 2007.pdf
Q2
Interim report 1 January - 30 June 2007.pdf
Presentation for interim report 1 January - 30 June 2007.pdf
Q1
Interim report 1 January - 31 March 2007.pdf
Presentation for interim report 1 January - 31 March 2007.pdf
2006
Oriola-KD Financial information January - June 2006.pdf
Q4
Financial statements 1 July - 31 December 2006.pdf
Presentation for financial statements 1 July - 31 December 2006.pdf
Q3
Interim report 1 July - 30 September 2006.pdf
Presentation for interim report 1 July - 30 September 2006.pdf
NEXT:
Q4 2019
English
Swedish
Finnish
Consumers
Pharmacies
Pharmacy Services
Brands
Pharmaceutical Companies
Expert services
Clinical services
Market and hospital access
Sales and marketing
Regulatory life cycle management
Real World Evidence
Patient support programs
Supply chain and logistics
Medicine importing services for a smooth solution
High-quality logistic services in the healthcare
Business Intelligence
Investors
Oriola as an Investment
Strategy and Targets
Key Figures
Operating environment
Acquisitions and Divestments
Analysts
Share information and Shareholders
Share Price Trends Tool
Total Return Calculator
Dividence Policy
Share Capital and Shares
Flagging Notifications
Consensus Estimates
Consensus Estimate chart
Conversion Right
Shareholders
Major Shareholders - shares
Major Shareholders - Votes
Silent Period
Financial Information
Key Figures
Long Term Targets
Latest Outlook
IFRS Principles
Investor Calendar
Investor Relations
Financial Reports
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Annual Reports
Corporate Governance
Shareholder Meetings
AGM 2020
AGM 2019
AGM 2018
AGM 2017
AGM 2016
AGM 2015
AGM 2014
AGM 2013
AGM 2012
AGM 2011
Shareholders' Nomination Board
The Board of Directors
Diversity Policy
Members of the Board
Board Committees
President and CEO
Group Management Team
Remuneration Statement
External Audit
Internal Supervision and Internal Audit
Risks
Insider Register
Articles of Association
Shareholders' Agreements
Disclosure Policy
Corporate Governance Statement 2019
Media
Careers
Open Vacancies
About us
Sustainability
Sustainability strategy
Availability of pharmaceuticals
Regulatory compliance
Supply Chain Management
Tax footprint
Oriola as an employer
Diversity
Carbon footprint
Materiality Assessment
Energy
Waste
History
Management
Strategy
Contact
LinkedIn
Tweet
Facebook